Brief: Immix Biopharma Confirms No Exposure To Silicon Valley Bank Or Silvergate Bank
11/03/2023 24:47
March 10 (Reuters) - Immix Biopharma Inc IMMX.O :
* IMMIX BIOPHARMA CONFIRMS NO EXPOSURE TO SILICON VALLEY
BANK OR
SILVERGATE BANK
* IMMIX BIOPHARMA - CONFIRMS THAT NEITHER IMMIXBIO, NOR ANY
OF ITS
SUBSIDIARIES, HAVE ANY EXPOSURE TO SILICON VALLEY BANK ("SVB")
OR SILVERGATE BANK
Source text for Eikon: ID:nGNXwlM7m
Further company coverage: IMMX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary